Skip to Content

NEW

A vastly improved search engine helps you find the latest on companies, business leaders, and news more easily.

SIGN IN

Matthew Perrone

Health
FDA authorizes Merck COVID pill a day after approving Pfizer’s
By
Matthew Perrone
and
The Associated Press
December 23, 2021
Health
Pfizer pill becomes first FDA-approved home COVID treatment
By
Matthew Perrone
and
The Associated Press
December 22, 2021
Health
FDA approves Pfizer and Moderna COVID-19 vaccine boosters for all adults
By
Lauran Neergaard,
Matthew Perrone,
and others
November 19, 2021
Health
Pfizer seeks emergency FDA authorization for COVID-19 pill
By
Matthew Perrone
and
The Associated Press
November 16, 2021
Health
FDA authorizes COVID vaccine for kids ages 5 to 11
By
Matthew Perrone,
Lauren NEERGAARD,
and others
October 29, 2021
Health
FDA panel backs Pfizer’s COVID vaccine for kids ages 5 to 11
By
Lauren NEERGAARD,
Matthew Perrone,
and others
October 26, 2021
Health
FDA approves Moderna and Johnson & Johnson boosters, as well as mixing COVID vaccines
By
Matthew Perrone,
Lauren NEERGAARD,
and others
October 20, 2021
Health
FDA advisors unanimously back Moderna COVID boosters for seniors and high risk groups
By
Lauren NEERGAARD,
Matthew Perrone,
and others
October 14, 2021
Health
FDA will not make a decision on Merck’s COVID antiviral pill until December
By
Matthew Perrone
and
The Associated Press
October 14, 2021
Health
FDA debates timeline for administering Johnson & Johnson booster shots
By
Matthew Perrone,
Lauren NEERGAARD,
and others
October 13, 2021
Health
FDA panel will advise on Johnson & Johnson booster shots this week
By
Lauran Neergaard,
Matthew Perrone,
and others
October 12, 2021
Health
Merck asks FDA to authorize its breakthrough COVID antiviral pill
By
Matthew Perrone
and
The Associated Press
October 11, 2021
Health
Merck says its experimental COVID-19 pill reduces hospitalizations and deaths by half
By
Matthew Perrone
and
The Associated Press
October 1, 2021
Health
FDA backs Pfizer COVID-19 boosters for seniors and high-risk
By
Matthew Perrone,
Lauren NEERGAARD,
and others
September 22, 2021
Health
The fate of Biden’s ambitious COVID booster plan lies in the hands of FDA advisors
By
Matthew Perrone,
Lauran Neergaard,
and others
September 17, 2021

1 - 15 of 27 results

1 - 15 of 27 results